Theres a Better Option Fella Health offers GLP-1s, though recent issues and access limits may make it less ideal for many
2.1 years in ELIXA)
In contrast, during fasting and hypoglycemic conditions, GIP acts to increase glucagon secretion with little effect on insulin release
It is what semaglutide and tirzepatide have delivered in real-world clinical practice over 2024 and 2025 - and that gap is instructive
What we did To better understand this emerging pattern, Mira conducted a survey of 310 women who use the Mira hormone monitor and were using GLP-1 medications such as Ozempic, Wegovy, Mounjaro, Zepbound, and others
Compounded medications degrade over time, and the BUD represents the last date the pharmacy guarantees the medication meets potency and sterility standards